AVRDB — Anteris Technologies Share News
0.000.00%
HealthcareMicro Cap
Brief: Anteris Technologies Posts HY Net Loss After Tax A$30.2 Million
Brief: Anteris Technologies Says Established A Sponsored Level 1 ADR Program In U.S.
Brief: Anteris Technologies Enters Agreement With V2vmedtech, Inc.
Australia's Anteris Technologies hits over 2-mth high on receiving U.S. patent
Brief: Anteris Technologies Announces Issuance Of Utility Patent For Novel Duravr Transcatheter Heart Valve
Australia's Anteris Technologies hits 4-week low on discounted placement
Brief: Anteris Technologies Announces A$35 Mln Capital Raise
Brief: Anteris Technologies Seeks Trading Halt
Brief: Anteris Technologies Says Entered Into Non-Binding Agreement With Yorkville Advisors Global
Brief: Anteris Technologies Seeks Trading Halt
Brief: Anteris Technologies Says US FDA Approves Early Feasibility Study For Duravr
Australia's Anteris Technologies climbs on FDA nod for heart device study
Brief: Anteris Technologies Records HY Revenues From Ordinary Activities A$2.5 Mln
Australia Stock Exchange release from ANTERIS TECH : Notification of cessation of securities - AVR
Australia Stock Exchange release from ANTERIS TECH : Application for quotation of securities - AVR
Australia Stock Exchange release from ANTERIS TECH : Cleansing Notice
Australia Stock Exchange release from ANTERIS TECH : Notification of cessation of securities - AVR
Australia Stock Exchange release from ANTERIS TECH : Application for quotation of securities - AVR
Australia Stock Exchange release from ANTERIS TECH : Change of Director's Interest Notice